A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US*

✍ Scribed by Charles, Meaghan St.; Minshall, Michael E.; Pandya, Bhavik J.; Baran, Robert W.; Tunis, Sandra L.

• Book ID: 120642740
• Publisher: Informa plc
• Year: 2009
• Tongue: English
• Weight: 192 KB
• Volume: 25
• Category: Article
• ISSN: 0300-7995
• DOI: 10.1185/03007990902870084